BioCentury

7:00 AM GMT, Apr 27, 2009
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Tysabri natalizumab: Post-marketing study data

In an update published on its website, Biogen Idec reported 6 confirmed cases of progressive multifocal leukoencephalopathy (PML) in patients receiving

Read the full 215 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.